3Saito A,Saito E,Handa R,et al.Influence of residual bone on recombinant human bone morphogenetic protein-2-induced periodontal regeneration in experimental periodontitis in dogs[J].J Periodontol,2009,80(6):961.
5Goncalves C,Rodrigues RMJ,Feres-Filho EJ,et al.Clinical effects of systemic and topical tetracycline therapy on chronic periodontal disease[J].Braz J Oral Sci,2004,3(8):384.
6El-Refaie K,Bowlin L,Mansfield K,et al.Release of tetracycline hydrochloride from electrospun poly(ethylene-co-vinylacetate),poly(lactic acid),and a blend[J].J Control Release,2002,81(1/2):57.
7Chang HI,Lau YC,Yan C,et al.Controlled release of an antibiotic,gentamicin sulphate,from gravity spun polycaprolactone fibers[J].J Biomed Mater Res A,2008,84(1):230.
7Jones DS, Woolfson AD, Brown AF, et al. Design, characterization and preliminary clinical evaluation of a novel mucoadhesive topical for mulation containing tetracycline forthe treatment of periodontal disease [J]. J Controlled Release,2000, 67 (2-3) : 357-368.
8[1]Walker CB,Gordon JM,McQuilkin SJ et al.Tetracycline:Levels achievable in gingival crevice fluid and in vitro effect on subgingival organisms. Part Ⅱ .Susceptibilities of periodontal bacteria.J Periodontol, 1981,52:613～616.
9[2]Wright TL,Ellen RP,Lacroix J-M et al. Effects of metronidazole on Porphyromonas gingivalis biofilms.J Periodont Res, 1997,32:473～477.
10[3]Sakellari D,Goodson JM,Soeransky SS et al.Concentration of 3 tetracyclines in plasma ,gingival crevice fluid and saliva. J Clin Periodontol,2000,27:53 ～60.
